
|Articles|August 15, 2004
Coated stents, alpha-blockers advance treatment of stones
New research on the potential of antibiotic-eluting stents and alpha-blockers that may speed or ease the passage of stones may lead to significant changes in urologic practices, according to Glenn M. Preminger, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
4
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
5











